Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOEL ESTEBAN RODRIGUEZ

Allopathic & Osteopathic Physicians Family Medicine Sports Medicine

NPI
1952780140
CMS profile
5300267
Location
HOUSTON, TX

General Payments · PY2018–2024

$3,512.12

  • Reported across 102 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$361.72

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $361.72 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $141.43 2
Bioventus LLC $60.93 3
Siemens Medical Solutions USA, Inc. $46.37 2
Ferring Pharmaceuticals Inc. $35.22 2
FIDIA PHARMA USA INC. $24.06 1
Avanos Medical $19.94 1
DePuy Synthes Sales Inc. $19.70 1
Medinc of Texas $14.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $143.35 3
PY2019 $581.95 18
PY2020 $310.20 18
PY2021 $451.94 18
PY2022 $900.16 17
PY2023 $762.80 15
PY2024 $361.72 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $116.91 03/19/2024 Food and Beverage Undisputed 01/23/2026 1111690620 CMS
Amgen Inc. $24.52 09/10/2024 Food and Beverage Undisputed 01/23/2026 1111690622 CMS
Avanos Medical $19.94 12/11/2024 Food and Beverage Undisputed 01/23/2026 1149308403 CMS
Bioventus LLC $15.17 04/04/2024 Food and Beverage Undisputed 01/23/2026 1137448323 CMS
Bioventus LLC $18.01 06/20/2024 Food and Beverage Undisputed 01/23/2026 1137448325 CMS
Bioventus LLC $27.75 09/04/2024 Food and Beverage Undisputed 01/23/2026 1137448327 CMS
DePuy Synthes Sales Inc. $19.70 05/28/2024 Food and Beverage Undisputed 01/23/2026 1077894238 CMS
Ferring Pharmaceuticals Inc. $14.07 03/28/2024 Food and Beverage Undisputed 01/23/2026 1137506220 CMS
Ferring Pharmaceuticals Inc. $21.15 08/12/2024 Food and Beverage Undisputed 01/23/2026 1137506225 CMS
Fidia Pharma USA Inc. $24.06 10/21/2024 Food and Beverage Undisputed 01/23/2026 1141158663 CMS
Medinc of Texas $14.07 08/08/2024 Food and Beverage Undisputed 01/23/2026 1125025765 CMS
Siemens Medical Solutions USA, Inc. $30.87 07/30/2024 Food and Beverage Undisputed 01/23/2026 1093690950 CMS
Siemens Medical Solutions USA, Inc. $15.50 11/01/2024 Food and Beverage Undisputed 01/23/2026 1093690952 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.